Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6MGM

Helix-Loop-helix motif of mouse DNA-binding protein inhibitor ID-1

6MGM の概要
エントリーDOI10.2210/pdb6mgm/pdb
関連するPDBエントリー5T9O
分子名称DNA-binding protein inhibitor ID-1 (2 entities in total)
機能のキーワードhelix-loop-helix dna-binding protein inhibitor, dna binding protein
由来する生物種Mus musculus (Mouse)
タンパク質・核酸の鎖数2
化学式量合計12528.42
構造登録者
Benezra, R.,Pavletich, N.P.,Goldgur, Y.,Gall, A.-L. (登録日: 2018-09-14, 公開日: 2019-09-18, 最終更新日: 2023-10-11)
主引用文献Wojnarowicz, P.M.,Lima E Silva, R.,Ohnaka, M.,Lee, S.B.,Chin, Y.,Kulukian, A.,Chang, S.H.,Desai, B.,Garcia Escolano, M.,Shah, R.,Garcia-Cao, M.,Xu, S.,Kadam, R.,Goldgur, Y.,Miller, M.A.,Ouerfelli, O.,Yang, G.,Arakawa, T.,Albanese, S.K.,Garland, W.A.,Stoller, G.,Chaudhary, J.,Norton, L.,Soni, R.K.,Philip, J.,Hendrickson, R.C.,Iavarone, A.,Dannenberg, A.J.,Chodera, J.D.,Pavletich, N.,Lasorella, A.,Campochiaro, P.A.,Benezra, R.
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization.
Cell Rep, 29:62-75.e7, 2019
Cited by
PubMed Abstract: Id helix-loop-helix (HLH) proteins (Id1-4) bind E protein bHLH transcription factors, preventing them from forming active transcription complexes that drive changes in cell states. Id proteins are primarily expressed during development to inhibit differentiation, but they become re-expressed in adult tissues in diseases of the vasculature and cancer. We show that the genetic loss of Id1/Id3 reduces ocular neovascularization in mouse models of wet age-related macular degeneration (AMD) and retinopathy of prematurity (ROP). An in silico screen identifies AGX51, a small-molecule Id antagonist. AGX51 inhibits the Id1-E47 interaction, leading to ubiquitin-mediated degradation of Ids, cell growth arrest, and reduced viability. AGX51 is well-tolerated in mice and phenocopies the genetic loss of Id expression in AMD and ROP models by inhibiting retinal neovascularization. Thus, AGX51 is a first-in-class compound that antagonizes an interaction formerly considered undruggable and that may have utility in the management of multiple diseases.
PubMed: 31577956
DOI: 10.1016/j.celrep.2019.08.073
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.791 Å)
構造検証レポート
Validation report summary of 6mgm
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon